EDEM1 and breast carcinoma: Furthermore, though DOX suppressed the growth of breast cancer cells, these suppressive effects were more substantial in the control group rather than the EDEM1 overexpression group, which indicated that EDEM1 could attenuate the anticancer effect of DOX (Fig. 7A to C).